Sanders Applauds GlaxoSmithKline for Capping Inhaler Costs at $35 Per Month
March 21, 2024
March 21, 2024
WASHINGTON, March 21 -- Sen. Bernie Sanders, I-Vermont, issued the following statement on March 20, 2024:
* * *
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday issued the following statement after GlaxoSmithKline (GSK), the largest manufacturer of inhaler products in the United States, announced that it would cap out-of-pocket costs at $35 per month for its asthma and COPD inhalers no later than J . . .
* * *
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday issued the following statement after GlaxoSmithKline (GSK), the largest manufacturer of inhaler products in the United States, announced that it would cap out-of-pocket costs at $35 per month for its asthma and COPD inhalers no later than J . . .